NDC 0225-0610

BENZEDREX 09-19-2014

Propylhexedrine

BENZEDREX 09-19-2014 is a Nasal Inhalant in the Human Otc Drug category. It is labeled and distributed by Bf Ascher And Co Inc. The primary component is Propylhexedrine.

• Product ID: 0225-0610_03e598d8-8da9-2dd0-e054-00144ff88e88
• NDC: 0225-0610
• Product Type: Human Otc Drug
• Proprietary Name: BENZEDREX 09-19-2014
• Generic Name: Propylhexedrine
• Dosage Form: Inhalant
• Route of Administration: NASAL
• Marketing Start Date: 2014-09-19
• Marketing Category: OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL
• Application Number: part341
• Labeler Name: BF ASCHER AND CO INC
• Substance Name: PROPYLHEXEDRINE
• Active Ingredient Strength: 250 mg/1
• NDC Exclude Flag: N
• Listing Certified Through: 2019-12-31

Packaging

NDC 0225-0610-23

1 INHALANT in 1 INHALER (0225-0610-23)

• Marketing Start Date: 2014-09-19
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0225-0610-23 [00225061023]

BENZEDREX 09-19-2014 INHALANT

• Marketing Category: OTC monograph final
• Application Number: part341
• Product Type: HUMAN OTC DRUG
• Billing Unit: EA
• Marketing Start Date: 2014-09-19

Drug Details

Active Ingredients

Ingredient	Strength
PROPYLHEXEDRINE	250 mg/1

OpenFDA Data

• SPL SET ID: 03a8ef3c-a808-6208-e054-00144ff8d46c
• Manufacturer:
  • BF ASCHER AND CO INC
• UNII:
  • LQU92IU8LL
• RxNorm Concept Unique ID - RxCUI:
  • 1361538
  • 1361536

NDC Crossover Matching brand name "BENZEDREX 09-19-2014" or generic name "Propylhexedrine"

NDC	Brand Name	Generic Name
0225-0610	BENZEDREX	PROPYLHEXEDRINE
0295-0100	Benzedrex Nasal Decongestant	Propylhexedrine